Fundz

TYBR Health reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEJul 21, 2026

Amount Raised

$30 Million

$30 Million per company press release (Jul 21, 2026)

Round Type

Series A

HoustonBiotechnologyHealthcare

Investors

Neovate Capital PartnersVensana CapitalMutual Capital Partners

Description

TYBR Health announced a $30 million Series A financing led by Vensana Capital and Mutual Capital Partners, with participation from Neovate Capital Partners and existing investors. The funds will be utilized to expand commercial access to the FDA-cleared B3 GEL® System and broaden its product indications. It will also support clinical studies evaluating tissue protection during orthopedic surgery. This financing aims to improve patient recovery through enhanced healing technologies.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as TYBR Health that raised within 45 days of this round, from Fundz verified event records.

  • CytoDyn raised $17M on September 1, 2026.
  • Tenon Medical raised $4.3M (Series A) on August 31, 2026.
  • Corvex Legacy Holdings raised $33M on August 31, 2026.
  • Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
  • Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
  • BioLineRx Ltd raised $3.8M on August 27, 2026.

Who to call at TYBR Health, and when

A new round usually means TYBR Health is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TYBR Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TYBR Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TYBR Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TYBR Health

Location

2450 Holcombe Blvd

Houston, Texas, United States

About

TYBR Health is a medical technology and regenerative medicine company dedicated to transforming the post-surgery experience through advanced patient recovery solutions. The company develops cutting-edge biomaterial therapies designed to simplify healing, reduce complications, and improve outcomes, driven by a team of passionate innovators committed to empowering patients throughout their recovery journey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TYBR Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsFrida M., Biomedical EngineerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TYBR Health's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

TYBR Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.